Ellen Zwarthoff
Erasmus Universiteit Rotterdam
H-index: 87
Europe-Netherlands
Top articles of Ellen Zwarthoff
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
A Genomic Urine Assay for Surveillance of Patients with Bladder Cancer Treated with Radiotherapy | European Urology Open Science | Florus C de Jong Iris G Ifle Angelique C van der Made Denise Kooper Joep J de Jong | 2024/4/1 |
PD36-02 A COMPOSITE BIOMARKER APPROACH TO SPARE NEOADJUVANT CHEMOTHERAPY IN SELECT MUSCLE-INVASIVE BLADDER CANCER PATIENTS | The Journal of Urology | Joep De Jong A Gordon Robertson Nick Beije John Martens Ellen Zwarthoff | 2023/4 |
A urine-based genomic assay improves risk stratification for patients with high-risk hematuria stratified according to the American Urological Association guidelines | European Urology Oncology | Joep J de Jong Olga M Pijpers Kim EM van Kessel Joost L Boormans Wim Van Criekinge | 2023/4/1 |
Comprehensive genomic characterization of early-stage bladder cancer from 438 patients by whole genome-and exome sequencing | Cancer Research | Frederik Prip Philippe Lamy Iver Nordentoft Sia Viborg Lindskrog Trine Strandgaard | 2023/4/4 |
Comprehensive molecular characterization reveals genomic and transcriptomic subtypes of metastatic urothelial carcinoma | European urology | J Alberto Nakauma-González Maud Rijnders Job van Riet Michiel S van der Heijden Jens Voortman | 2022/4/1 |
Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patients | Urologic Oncology: Seminars and Original Investigations | Laura S Mertens Francesco Claps Roman Mayr Peter J Bostrom Shahrokh F Shariat | 2022/3/1 |
A genomic urine assay to detect urinary tract recurrences in patients with bladder cancer treated with radiotherapy | Florus C de Jong Iris I Ifle Denise Kooper Angelique CJ van der Made Joep J De Jong | 2022/2/1 | |
Method of diagnosing bladder cancer | 2022/1/11 | ||
A urine-based molecular assay refines the risk stratification of the recent American Urological Association guideline on hematuria | Joep de Jong Olga Pijpers Kim van Kessel Joost Boormans Wim Van Criekinge | 2022 | |
MP54-07 A URINE-BASED MOLECULAR ASSAY REFINES THE RISK STRATIFICATION OF THE RECENT AMERICAN UROLOGICAL ASSOCIATION GUIDELINE ON HEMATURIA | The Journal of Urology | Joep de Jong Olga Pijpers Kim van Kessel Joost Boormans Wim van Criekinge | 2022/5 |
MP59-03 A URINE-BASED MUTATION-METHYLATION ASSAY FOR THE SURVEILLANCE OF HIGH RISK NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS | The Journal of Urology | Joep de Jong Florus de Jong Angelique Ziel-van der Made Ties Hagdorn Egbert Boeve | 2022/5 |
T1 substaging of nonmuscle invasive bladder cancer is associated with bacillus Calmette-Guérin failure and improves patient stratification at diagnosis | The Journal of Urology | Florus C de Jong Robert F Hoedemaeker Vebjørn Kvikstad Jolien TM Mensink Joep J de Jong | 2021/3 |
Transcriptomic analysis of BCG-treated T1HG bladder cancer patients identifies an EMT-basal subgroup with immune suppressive characteristics at high risk of BCG-failure | Cancer Research | Florus C De Jong Teemu D Laajala Robert F Hoedemaeker Sébastien Rinaldetti Jolien T Mensink | 2021/7/1 |
The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder | International Journal of Cancer | Thomas van Doeveren Jose A Nakauma‐Gonzalez Andrew S Mason Geert JLH van Leenders Tahlita CM Zuiverloon | 2021/2/15 |
Integrative genomic and transcriptomic characterization of metastatic urothelial carcinoma | Cancer Research | Maud Rijnders J Alberto Nakauma-Gonzalez Job van Riet Michiel S van der Heijden Jens Voortman | 2021/7/1 |
Re: Divergent Biological Response to Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer | Journal of urology | R Seiler EA Gibb NQ Wang HZ Oo HM Lam | 2021/6/1 |
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer | Nature communications | Sia Viborg Lindskrog Frederik Prip Philippe Lamy Ann Taber Clarice S Groeneveld | 2021/4/16 |
MP66-01 RNA-SEQUENCING OF BCG TREATED BLADDER CANCER PATIENTS IDENTIFIES PATIENTS WITH AGGRESSIVE AND IMMUNE SUPPRESSIVE TUMORS AT RISK OF BCG FAILURE | Journal of Urology | Florus C de Jong Teemu D Laajala Robert F Hoedemaeker Jolien TM Mensink Sébastien Rinaldetti | 2021/9/1 |
Molecular characterization reveals genomic and transcriptomic subtypes of metastatic urothelial carcinoma | M Rijnders J van Riet MS van der Heijden J Voortman E Cuppen | 2021/3/17 | |
Differential pathway analyses of BCG-treated T1HG bladder cancer using Philips OncoSignal: A pilot study | Cancer Research | Florus C De Jong Teemu D Laajala Robert F Hoedemaeker Sébastien Rinaldetti Jolien T Mensink | 2021/7/1 |
